Nicolas Michel Georges Koch
$ALC.ZU (Alcon Inc.) 's attempt to acquire $STAA (STAAR Surgical Company) is officially over! Alcon is a global leader in eye care (surgical equipment, vision care, ophthalmology devices) STAAR Surgical is a more focused player, best known for its Implantable Collamer Lenses (ICL), used as an alternative to laser eye surgery, with strong long-term exposure to rising global myopia. In August 2025, Alcon agreed to buy STAAR for 28 usd/share in cash, valuing the company at 1.5bn usd. After pushback from shareholders, the offer was increased in December 2025 to 30.75 usd/share (~70% premium). Despite this, key shareholders opposed the deal, arguing it undervalued STAARโ€™s long-term potential. On January 6, 2026, STAAR shareholders formally rejected the transaction, and the merger was terminated. Takeaway: ๐Ÿ‘‡ This wasnโ€™t a strategic mismatch โ€” the deal made sense industrially. It was a valuation and confidence issue. STAAR investors chose optionality and independence over a cash premium, while Alcon now has to look elsewhere to deploy capital in surgical vision correction. Yet, the stock has been reacting -6% following the announcement. Worth watching how STAA executes standalone from here โ€” and how ALC redeploys its M&A firepower. Stay tuned! -------------------------------- ๐ˆ ๐จ๐ฎ๐ญ๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐Ÿ๐จ๐ซ ๐Ÿ ๐ฒ๐ž๐š๐ซ๐ฌ. ๐‚๐จ๐ฉ๐ฒ-๐ญ๐ซ๐š๐๐ž ๐ฆ๐ž to be part of this ๐Ÿš€ (๐ถ๐‘œ๐‘๐‘ฆ-๐‘ก๐‘Ÿ๐‘Ž๐‘‘๐‘–๐‘›๐‘” ๐‘–๐‘  ๐‘“๐‘Ÿ๐‘’๐‘’ ๐‘œ๐‘“ ๐‘โ„Ž๐‘Ž๐‘Ÿ๐‘”๐‘’ ๐‘–๐‘› ๐ธ๐‘ก๐‘œ๐‘Ÿ๐‘œ, ๐‘ ๐‘ก๐‘Ž๐‘Ÿ๐‘ก๐‘–๐‘›๐‘” ๐‘ค๐‘–๐‘กโ„Ž 200๐‘ข๐‘ ๐‘‘)
null
.